1. Home
  2. MRKR vs CNEY Comparison

MRKR vs CNEY Comparison

Compare MRKR & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRKR
  • CNEY
  • Stock Information
  • Founded
  • MRKR N/A
  • CNEY 2018
  • Country
  • MRKR United States
  • CNEY China
  • Employees
  • MRKR N/A
  • CNEY N/A
  • Industry
  • MRKR Biotechnology: Pharmaceutical Preparations
  • CNEY Major Chemicals
  • Sector
  • MRKR Health Care
  • CNEY Industrials
  • Exchange
  • MRKR Nasdaq
  • CNEY Nasdaq
  • Market Cap
  • MRKR 11.6M
  • CNEY 11.3M
  • IPO Year
  • MRKR N/A
  • CNEY 2021
  • Fundamental
  • Price
  • MRKR $0.94
  • CNEY $1.71
  • Analyst Decision
  • MRKR Strong Buy
  • CNEY
  • Analyst Count
  • MRKR 2
  • CNEY 0
  • Target Price
  • MRKR $10.25
  • CNEY N/A
  • AVG Volume (30 Days)
  • MRKR 156.4K
  • CNEY 11.5K
  • Earning Date
  • MRKR 11-14-2025
  • CNEY 01-01-0001
  • Dividend Yield
  • MRKR N/A
  • CNEY N/A
  • EPS Growth
  • MRKR N/A
  • CNEY N/A
  • EPS
  • MRKR N/A
  • CNEY N/A
  • Revenue
  • MRKR $5,388,071.00
  • CNEY $36,049,275.00
  • Revenue This Year
  • MRKR N/A
  • CNEY N/A
  • Revenue Next Year
  • MRKR $9.06
  • CNEY N/A
  • P/E Ratio
  • MRKR N/A
  • CNEY N/A
  • Revenue Growth
  • MRKR 44.55
  • CNEY N/A
  • 52 Week Low
  • MRKR $0.81
  • CNEY $1.56
  • 52 Week High
  • MRKR $5.95
  • CNEY $21.61
  • Technical
  • Relative Strength Index (RSI)
  • MRKR 46.45
  • CNEY 35.94
  • Support Level
  • MRKR $0.84
  • CNEY $1.65
  • Resistance Level
  • MRKR $1.02
  • CNEY $1.96
  • Average True Range (ATR)
  • MRKR 0.05
  • CNEY 0.10
  • MACD
  • MRKR -0.00
  • CNEY -0.01
  • Stochastic Oscillator
  • MRKR 46.38
  • CNEY 14.12

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

About CNEY CN Energy Group Inc.

CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.

Share on Social Networks: